PulmonaryOncoGuides is an open-access medical information initiative developed to address the acute clinical need for evidence-based navigation in cancer-related pulmonary toxicities, drug-induced interstitial lung disease (ILD), and respiratory complications.
To provide cancer patients, oncologists, and pulmonologists with transparent, guideline-grounded tools—including validated ICI pneumonitis steroid tapers, bleomycin DLCO risk matrices, and malignant pleural effusion algorithms—alongside direct links to 100+ global respiratory grants and statutory oxygen benefits.
For questions or editorial feedback, please visit our Contact Page or review our Editorial & Evidence Policy.